Navigation LinksBiology NewsHealth NewsBiology TechnologyMedicine Technology


Helix Biopharma to Present L-DOS47 Lung Cancer Research Findings at the Fourth International Conference on Tumor Microenvironment in Florence, Italy

- Helix BioPharma Corp. (TSX: HBP /Frankfurt: WKN918864) AURORA, ON, March 5 /CNW/Dr. Heman Chao, Vice President of Researchat Helix BioPharma Corp., a developer of novel cancer therapeutics,will be presenting a scientific poster at the Fourth InternationalConference on Tumor Microenvironment, which runs from March 6th to10th in Florence, Italy. The conference, hosted by the...

Replidyne Phase II Pediatric Trial Meets Primary Objective

LOUISVILLE, Colo., March 06, 2007 /PRNewswire-FirstCall/ --Replidyne, Inc. announced today that it has completed its Phase IIclinical trial using faropenem medoxomil (faropenem) in pediatricpatients with acute otitis media (AOM), a common infection of themiddle ear. Initial analyses of the study results show that it metits primary objective to show that faropenem was effective ineradicatin...

DVT Awareness Survey Findings: Heart and Respiratory Patients

WASHINGTON, March 06, 2007 /PRNewswire/ -- Up to two millionAmericans are affected each year by DVT, with up to 600,000hospitalized. Its primary complication, pulmonary embolism (PE),claims up to 300,000 lives annually -- more than breast cancer andAIDS combined. People who suffer from cardiovascular disease may beat increased risk for DVT, because these factors also heighten thelikelihood...

Pozen Announces Positive Outcome for PA 325

Chapel Hill, N.C., March 6, 2007-Pozen Inc. (NASDAQ: POZN),today announced top-line results of its "Safer Aspirin" PA 325proof-of-concept study conducted during the fourth quarter of 2006.PA 325 is a patented formulation of 325mg of aspirin surrounded bya 20mg coating of an immediate release formulation of a proton pumpinhibitor. The PA 325, 28 day study, involved two groups of 40 subject...

Advanced Magnetics Announces Presentation of Ferumoxytol Data at the National Kidney Foundation 2007 Spring Clinical Meetings

CAMBRIDGE, Mass., March 06, 2007 /PRNewswire-FirstCall/ --Advanced Magnetics today announced that data from three completedPhase III multi- center clinical studies of ferumoxytol as anintravenous iron replacement therapeutic will be presented duringthe National Kidney Foundation (NKF) 2007 Spring Clinical Meetingstaking place April 10th through 14th in Orlando, Florida. Twoposters containi...

POZEN Announces Positive Outcome for PA 325 Proof of Concept Study

CHAPEL HILL, N.C.--(BUSINESS WIRE)--Mar 6, 2007 - POZEN Inc.(NASDAQ: POZN), today announced top-line results of its "SaferAspirin" PA 325 proof-of-concept study conducted during the fourthquarter of 2006. PA 325 is a patented formulation of 325mg ofaspirin surrounded by a 20mg coating of an immediate releaseformulation of a proton pump inhibitor. The PA 325, 28 day study, involved two group...

Nventa Announces Presentation of Positive HspE7 Data from NCI-Sponsored Clinical Trial in Cervical Dysplasia

- 78 Percent of Patients Showed Complete Response or Reduction ofLesion Size by More than Fifty Percent - SAN DIEGO, CA, March 05, 2007 /PRNewswire-FirstCall/ - NventaBiopharmaceuticals Corporation today announced the presentation ofpositive results from a clinical trial examining the safety andefficacy of pilot process HspE7, an investigational therapeuticvaccine for human papillomavirus (...

AOP Orphan Pharmaceuticals and Lantibio Announce Positive Phase II Study with Novel Cystic Fibrosis Therapy

VIENNA, Austria and CHAPEL HILL, N.C., US, March 06, 2007/PRNewswire/ -- AOP Orphan Pharmaceuticals AG ("AOP Orphan") andLantibio, Inc. ("Lantibio") today announced positive final resultsfrom their placebo controlled, double-blinded Phase II clinicalstudy of Moli1901, an experimental compound to treat cysticfibrosis ("CF"). Moli1901 is being developed by AOP Orphan inEurope under a licensi...

Advanced Cell Technology's Ability to Rescue Vision in Blind Rats Noted in Scientific American

ALAMEDA, Calif.--(BUSINESS WIRE)--Mar 5, 2007 - Advanced CellTechnology, Inc.'s (OTCBB: ACTC) ability to rescue vision in blindrats was noted in Scientific American's March 2007 issue as thelead story of its News Scan section. The full text of the article,which notes Advanced Cell's ability to "coax embryonic stem cellsto turn into transplantable retinal pigment epithelial (RPE)tissue," is...

Accentia Biopharmaceuticals Scientific Presentations Demonstrate Increasing Acceptance of Fungal Etiology of Chronic Sinusitis at the Annual Meeting of the American Academy of Allergy, Asthma, and Immunology

TAMPA, Fla.--(BUSINESS WIRE)--Mar 7, 2007 - AccentiaBiopharmaceuticals, Inc. (NASDAQ: ABPI), presented three posters atthe Annual Meeting of the American Academy of Allergy, Asthma, andImmunology from February 23 - 27, 2007 in San Diego, CA. Theposters discussed findings from a survey of 202 otolaryngologists(ENTs) and allergists in the U.S., U.K., France, and Germany on theburden of chroni...
[next]
(Date:4/18/2019)... ... April 18, 2019 , ... ... enhancing energy, concentration, memory, relaxation and restful sleep to support a healthy mind ... to provide mental clarity, focus and vitality. , The portfolio includes a total ...
(Date:4/18/2019)... ... April 18, 2019 , ... ... best provider for their care. Through the rise of online review sites and ... of interaction and transparency when making important purchasing decisions online. In order to ...
(Date:4/17/2019)... ... April 17, 2019 , ... Ramneek Kumar Talwar and Vineet ... Gwangju, Korea, and has highly evaluated and confirmed iRINGER’s technology, a product that’s ... discussion of a potential partnership since then. , After sharing relevant ...
(Date:4/17/2019)... , ... April 17, 2019 , ... ... on advances in revolutionary diagnostic technologies. This episode is scheduled to air 3Q ... this segment, Innovations will focus on Credo Biomedical Pte. Ltd. (Credo Biomedical), a ...
(Date:4/17/2019)... , ... April 17, 2019 , ... Tune in Wednesday, ... Women’s Excellence who overcame infertility and endometriosis with robotic surgery. Hosts Dr. Jonathan ... of robotic surgery for patients and the impact robotic surgery can have on a ...
Breaking Medicine News(10 mins):
... rankings aim to help families choose best option , , ... Medicare and Medicaid Services unveiled an updated Web site ... for elderly Americans and their families. , The updated ... similar to that used for hotels and motels, to ...
... NY, December 18, 2008Medical acupuncture, which is acupuncture performed ... school, is being used increasingly for pain control. Richard ... , a peer-reviewed journal ( www.liebertpub.com/acu ) and the ... is at the forefront of these efforts in the ...
... the European Association of Urology (EAU) will be held from ... (SE). The scientific programme covers the whole range of the ... it will all be discussed at the congress. ... are extended to a full-day event called EAU International Day ...
... study,s design may be to blame for desmoteplase,s poor showing, ... experimental clot-busting drug derived from the saliva of the vampire ... trial. , But hope for the drug, called desmoteplase, remains ... large enough to provide clear results. , "The sample size ...
... who suffer from thinning hair and hair loss with an all-natural ... all-natural DHT blockers with no side effects. , ... ... offering patients who suffer from thinning hair and hair loss with ...
... drug eluting stents (DES) stents coated with medication to ... angioplasty had better outcomes one year later than patients with ... published in CMAJ http://www.cmaj.ca/press/080050.pdf . , Mortality ... stents was significantly lower than for those with bare metal ...
Cached Medicine News:
... Direct has been selling replacement ... 1996, and we are extremely ... guarantee. Check out our catalog ... our discount light bulbs specials. ...
... has been selling replacement bulbs ... and we are extremely proud ... Check out our catalog of ... discount light bulbs specials. ...
... has been selling replacement bulbs ... and we are extremely proud ... Check out our catalog of ... discount light bulbs specials. ...
... Direct has been selling replacement ... 1996, and we are extremely ... guarantee. Check out our catalog ... our discount light bulbs specials. ...
Medicine Products:
(Date:4/17/2019)... CHARLOTTE, N.C. and ATLANTA, Ga. (PRWEB) , ... ... ... provider of financial solutions to healthcare providers and patients, announced today it has ... not disclosed. , Founded in 2012, Omni Holdings is the leading medical lien ...
(Date:4/17/2019)... ... April 17, 2019 , ... Lillibridge Healthcare Services Inc., a ... owners and operators of medical office buildings (MOBs), will sponsor and host three ... Owners and Managers Association (BOMA) International Medical Office Buildings + Healthcare Facilities Conference ...
(Date:4/17/2019)... Pa. (PRWEB) , ... April 17, 2019 , ... ... even those with sensory needs or on the autism spectrum, have an amazing ... Autism Center designation, which is awarded by the International Board of Credentialing and ...
Breaking Medicine Technology:
... Nov. 3, 2011 Intellect Neurosciences, Inc. (OTCBB: ... and development of disease-modifying therapeutic agents for the ... today that it has filed a response and ... methods application Serial  No. 10/084,380, one of several ...
... Nov. 3, 2011 Ellman® International, ... aesthetic procedures including the Pelleve® Wrinkle Reduction System, ... dermatology community at the American Society for Dermatologic ... an innovative, fully flexible CO2 laser system for fractional ...
Cached Medicine Technology: